series-b
Stage
About
Pelage Pharmaceuticals develops a topical, non-invasive small molecule drug, PP405, which activates dormant hair follicle stem cells to restore hair growth in conditions such as androgenetic alopecia.
Explore Pelage Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.